Eli Lilly is Overvalued

By
-
0
156

The investment newsletter Seeking Alpha reports that Eli Lilly’s research woes, including the halting of research into a new antipsychotic, mean that Lilly’s stock is overvalued.

Abstract → 

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous article“Lithium Toxicity – What You Need to Know”
Next articleEarly-Life Stress and Epigenetic Alterations
Kermit Cole
Kermit Cole
Kermit Cole is a licensed marriage and family therapist based in Santa Fe, New Mexico. He and his partner, Luisa Putnam, joined by their mutual interest in working with trauma and psychosis, studied Open Dialogue in Finland and Peer-supported Open Dialogue in the UK in order to practice and teach as a team. In 2011, they joined with Robert Whitaker to found the Mad in America website

LEAVE A REPLY